Related Experiment Videos

Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized

Lei Zhang1, Shuning Zhang, Hong Jiang

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, 180 Fenglin Road, Shanghai, China.

Clinical Cardiology
|February 8, 2011
PubMed

Insights

Statin treatment significantly improves cardiac function and reduces ventricular remodeling in patients with chronic heart failure (CHF). This meta-analysis confirms statins

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • The efficacy of statin therapy in patients with chronic heart failure (CHF) is not definitively established.
  • Investigating the potential benefits of statins on cardiac function and ventricular remodeling in CHF patients is crucial.

Purpose of the Study:

  • To evaluate the impact of statin treatment on cardiac function and ventricular remodeling in patients with chronic heart failure (CHF).
  • To synthesize evidence from randomized controlled trials (RCTs) to determine the overall effect of statins in CHF.

Main Methods:

  • A systematic literature search was conducted across PubMed, MEDLINE, EMBASE, and EBM Reviews for relevant RCTs.
  • Data extraction and quality assessment were performed independently by two reviewers.
  • Pooled analysis using random-effects models was employed to calculate weighted mean differences (WMD) and 95% confidence intervals (CI).

Main Results:

  • Eleven trials involving 590 patients were analyzed.
  • Statin treatment significantly increased left ventricular ejection fraction (WMD: 3.35%).
  • Statins also led to significant reductions in left ventricular end-diastolic diameter, left ventricular end-systolic diameter, B-type natriuretic peptide levels, and New York Heart Association functional class.

Conclusions:

  • Current evidence suggests that statin therapy offers significant benefits for patients with chronic heart failure (CHF).
  • Statin use is associated with improved cardiac function, enhanced clinical symptoms, and amelioration of left ventricular remodeling in CHF patients.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...